ArticleCancers2023

A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres.

Venturina Stagni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.